Peter M. Fong
Independent Chairman of the BoardDr. Peter M. Fong, Ph.D., serves as Board Executive Director of Corxel Pharmaceuticals (Shanghai) Co., Ltd., Corxel Pharmaceuticals, Inc. and Corxel Pharmaceuticals Limited. He previously served as the founding Chief Executive Officer of CORXEL during its formation in 2019/2020. He serves as Partner and President from 2024 at RTW Investments, LP. Previously he served as Chief Development Officer at RTW Investments, LP. till 2024. In addition to his broad management and oversight of the firm, he has retained his role as head of Asset Development and Financing (ADF). One of ADF’s primary responsibilities is the creation and incubation of RTW-founded companies. He also serves as founding Chief Executive Officer and board member of RTW’s incubated companies, building their management teams, pipelines and drug development capabilities with the goal of creating the next generation of leading biotech firms capable of bringing life-saving medicines to patients. He currently serves on the board of directors for both Ji Xing Pharmaceuticals and Yarrow Biotechnologies, which were founded by RTW under his leadership. He served as a Senior Principal at Flagship Pioneering since joining the firm in 2018 till November 2019. Previously, he worked in oncology business development at Genentech. He has also worked at Memorial Sloan-Kettering, where he managed their New Ventures and Business Development group. Prior to Memorial, he also co-founded Carigent Therapeutics. He received his Ph.D. in bioengineering from Yale University, where he also completed his M.Phil and M.S in Bio Engineering between 1998 and 2003. He received his B.S. in biochemistry from Indiana University, Bloomington from 1991 to 1995.
Positions
- Company NameRocket Pharmaceuticals, Inc.Stock CodeRCKTPositionIndependent Chairman of the BoardColleagues
- GDGaurav D. ShahCEO & Director
- MLMartin Louis WilsonGen. Counsel, Secretary, Interim Prin. Financial Officer, Chief Comp. Officer & Chief Corp. Officer
- CSChristopher StevensChief Operating Officer
- JMJoseph ManhedePrincipal Accounting Officer
- JSJonathan SchwartzChief Science & Gene Therapy Officer
- CBCarsten BoessIndependent Director
- DPDavid P. SouthwellIndependent Director
- RTRoderick Tze Ian WongDirector
